Antroquinonol was reported to have the potential to activate Nrf-2, decrease ethanol-induced oxidative stress in hepatic cells [27], and ameliorate the progression of focal segmental glomerulosclerosis in mice through reducing oxidative stress [9]. This evidence concerns the gene NFE2L2 and focal segmental glomerulosclerosis.